FDA Approved: MUPIROCIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

The FDA approved a supplemental application for mupirocin from Padagis Israel Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impetigo
• Nasal Carriage of Staphylococcus Aureus
• Staphylococcus Aureus Infection

Drugs mentioned

• Mupirocin (Mupirocin)

Snippet

SUPPL AP for MUPIROCIN (MUPIROCIN)